EMPIRE CONSULTING GROUP

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

HR 9504-The Tax-Exempt Hospital Transparency Act. 340B Program Violations. PBM reform. Issues related to Most Favored Nations. Issues related to health access.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.